Vertex Pharmaceuticals (VRTX) closed up more than +5% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. AbbVie (ABBV) closed up by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback